4Pignon J P, Arriagada R, Idhe D, et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer [J]. N Engl J Med, 1992,327(23) : 1618-1624.
5Warde P, Payne D. Does thoracic irradiation improve survival and local control in limited-stage small-cell lung cancer? A meta-anatysis [J]. J Clin Oncol, 1992,10(6):890-895.
6Fukuoka M, Furuse K, Saijo N, et al. Randomized trial of cyclophosphamide, doxorubicin, and vincristine versus cisplatin and etoposide versus ahernation of theseregimens in small-cell lung cancer [J]. J Natl Cancer Inst, 1991,83(12): 855-861.
7Sandier A B. Current management of small cell lung cancer [J]. Semin Oncol, 1997,24(4):463-476.
8Sundstrom S, Bremnes R M, Kaasa S, et al. Cisplatin and etoposide regimen is superior to eyelophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase Ⅲ trial with 5 years' follow-up [J]. J Clin Oncol, 2002,20(24) :4665-4672.
9Faivre-Finn C, Lee L W, Lorigan P, et al. Thoracic radiotherapy for limited-stage small cell lung cancer: controversies and future developments[J]. Clin Oncol (R Coil Radiol), 2005,17(8) :591-598.
10Zelen M. Keynote address on biostatistics and data retrieval [J]. Cancer Chemother Rep (part 3), 1973,4(2):31-42.
4Brade AM,Tannock IF.Scheduling of radiation and chemotherapy for limited-stage small-cell lung cancer repopulation as a cause of treatment failure[J].J Clin Oncol,2006,24(24):3815.
5De Ruysscher D,Pijls-Johannesma M,Bentzen SM,et al.Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer[J].J Clin Oncol,2006,24:1052.
6Pijls-Johannesma M,De Ruysscher D,Vansteenkiste J,et al.Timing of chest radintherapy in patients with limited stage small cell lung cancer:A systematic review and meta-analysis of randomised controlled trials[J].Cancer Treat Rev,2007,33 (5):461.
7Fried DB,Morris DE,Poole C,et al.Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer[J].Clin Oncol,2004,22 (23):4837.
8De Ruysscher D.Treatment of limited disease small cell lung cancer[J].EurJ Cancer,2009,1:425.
9Takada M,Fukuoka M,Kawahara M,et al.Phase Ⅲ study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage smallcell lung cancer results of the Japan Clinical Oncology Group Study9104[J].J Clin Oncol,2002,20 (14):3054.
10Schild SE,Bonner JA,Hillman S,et al.Results of a phase Ⅱ study of high-dose thoracic radiation therapy with concurrent cisplatin and etoposide in limited-stage smallcell lung cancer (NCCTG 95-20-53)[J].J Clin Oncol,2007,25 (21):3124.
